Genos is one of those startups using a next-generation sequencing process to both give you a good idea of your heredity on a deeper level and give researchers a crowdsourced genetic map to help with disease discovery.
The startup says it will sequence your whole genome in the near future, but is starting by sequencing your exome — or all the genes that translate their information into proteins in a genome. The exome is especially important in discovering diseases caused by rare genetic variants.
23andMe recently halted this type of next-gen sequencing and founder Anne Wojcicki called it “the hot, shiny object” of the industry…“But what you’re going to do with all that information is extremely complicated,” she said….
…[I]nstead of asking people to sign a blanket consent form, Genos plans to incentivize people by paying for their information each time.
Will the economics work? That part is unclear. How much Genos will pay is up for debate at the moment, though the company says it will be revealing how much participants could expect to make [in the near future.]
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Genetics startup Genos wants to pay you for your DNA data